PWE-071 Efficacy Of Infliximab As Second-line Biologic In Crohn’s Disease

E Russo; R Hackett; S Campbell; JO Lindsay; PM Irving; TR Orchard

doi:10.1136/gutjnl-2014-307263.331

Article info

PDF

Poster presentations

Inflammatory bowel disease II

PWE-071 Efficacy Of Infliximab As Second-line Biologic In Crohn’s Disease

Free

Authors

E Russo 1Medicine, Imperial College London, UK PubMed articles Google scholar articles
R Hackett 2Barts and the London School of Medicine and Dentistry, London, UK PubMed articles Google scholar articles
S Campbell 3Gastroenterology, MAnchester Royal Infirmary, Manchester, UK PubMed articles Google scholar articles
JO Lindsay 4Gastroenterology, Barts and the London NHS Trust, London, UK PubMed articles Google scholar articles
PM Irving 5Gastroenterology, Guy’s and St Thomas’ Hospitals, London, UK PubMed articles Google scholar articles
TR Orchard 6Gastroenterology, St Mary’s Hospital, London, UK PubMed articles Google scholar articles

Citation

Russo E, Hackett R, Campbell S, et al

PWE-071 Efficacy Of Infliximab As Second-line Biologic In Crohn’s Disease

Gut 2014;63:A154-A155.

Publication history

First published June 9, 2014.

Online issue publication

April 18, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password